Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PEGGS, Karl S")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 33

  • Page / 2
Export

Selection :

  • and

Immune reconstitution following haematopoietic stem cell transplantationPEGGS, Karl S; MACKINNON, Stephen.British journal of haematology. 2004, Vol 124, Num 4, pp 407-420, issn 0007-1048, 14 p.Article

Cellular therapy: donor lymphocyte infusion : Hematopoietic stem cell transplantationPEGGS, Karl S; MACKINNON, Stephen.Current opinion in hematology. 2001, Vol 8, Num 6, pp 349-354, issn 1065-6251Article

Co-stimulatory pathways in lymphocyte regulation : the immunoglobulin superfamilyPEGGS, Karl S; ALLISON, James P.British journal of haematology. 2005, Vol 130, Num 6, pp 809-824, issn 0007-1048, 16 p.Article

Management of multidrug-resistant viruses in the immunocompromised hostSELLAR, Rob S; PEGGS, Karl S.British journal of haematology. 2012, Vol 156, Num 5, pp 559-572, issn 0007-1048, 14 p.Article

Allogeneic transplantation for Hodgkin lymphomaPEGGS, Karl S; ANDERLINI, Paolo; SUREDA, Anna et al.British journal of haematology. 2008, Vol 143, Num 4, pp 468-480, issn 0007-1048, 13 p.Article

Allogeneic transplantation in the UK: an aggregation of marginal gains?THOMSON, Kirsty J; PEGGS, Karl S.British journal of haematology. 2013, Vol 163, Num 2, pp 149-159, issn 0007-1048, 11 p.Article

Exploiting graft-versus-tumour responses using donor leukocyte infusionsPEGGS, Karl S; MACKINNON, Stephen.Baillière's best practice & research. Clinical haematology. 2001, Vol 14, Num 4, pp 723-739, issn 1521-6926Article

Role of allogeneic stem cell transplantation in multiple myelomaTHOMSON, Kirsty J; PEGGS, Karl S.Expert review of anticancer therapy. 2005, Vol 5, Num 3, pp 455-464, issn 1473-7140, 10 p.Article

The role of allogeneic transplantation in non-Hodgkin's lymphomaPEGGS, Karl S; MACKINNON, Stephen; LINCH, David C et al.British journal of haematology. 2005, Vol 128, Num 2, pp 153-168, issn 0007-1048, 16 p.Article

Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradicationQUEZADA, Sergio A; PEGGS, Karl S; SIMPSON, Tyler R et al.Immunological reviews. 2011, Vol 241, pp 104-118, issn 0105-2896, 15 p.Article

Assessing diversity: immune reconstitution and T-cell receptor BV spectratype analysis following stem cell transplantationPEGGS, Karl S; VERFUERTH, Stephanie; D'SA, Shirley et al.British journal of haematology. 2003, Vol 120, Num 1, pp 154-165, issn 0007-1048, 12 p.Article

Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapyPEGGS, Karl S; QUEZADA, Sergio A; ALLISON, James P et al.Immunological reviews. 2008, Vol 224, pp 141-165, issn 0105-2896, 25 p.Article

Guideline on the management of primary resistant and relapsed classical Hodgkin lymphomaCOLLINS, Graham P; PARKER, Anne N; POCOCK, Christopher et al.British journal of haematology. 2014, Vol 164, Num 1, pp 39-52, issn 0007-1048, 14 p.Article

HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioningMEAD, Adam J; THOMSON, Kirsty J; LINCH, David C et al.Blood. 2010, Vol 115, Num 25, pp 5147-5153, issn 0006-4971, 7 p.Article

Donor Lymphocyte Infusions Modulate Relapse Risk in Mixed Chimeras and Induce Durable Salvage in Relapsed Patients After T-Cell―Depleted Allogeneic Transplantation for Hodgkin's LymphomaPEGGS, Karl S; KAYANI, Irfan; THOMSON, Kirsty J et al.Journal of clinical oncology. 2011, Vol 29, Num 8, pp 971-978, issn 0732-183X, 8 p.Article

Epitope Landscape in Breast and Colorectal CancerSEGAL, Neil H; PARSONS, D. Williams; PEGGS, Karl S et al.Cancer research (Baltimore). 2008, Vol 68, Num 3, pp 889-892, issn 0008-5472, 4 p.Article

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. CommentaryCORRADINI, Paolo; FARINA, Lucia; DOGAN, Ahmet et al.Lancet (British edition). 2005, Vol 365, Num 9475, pp 1906-1908, issn 0140-6736, 11 p.Article

Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposureKOTHARI, Jaimal; PEGGS, Karl S; BIRD, Antonia et al.British journal of haematology. 2014, Vol 165, Num 3, pp 334-340, issn 0007-1048, 7 p.Article

Adenoviremia Has Limited Clinical Impact in the Majority of Patients Following Alemtuzumab-Based Allogeneic Stem Cell Transplantation in AdultsSIVE, Jonathan I; THOMSON, Kirsty J; MORRIS, Emma C et al.Clinical infectious diseases. 2012, Vol 55, Num 10, pp 1362-1370, issn 1058-4838, 9 p.Article

Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell TransplantationPEGGS, Karl S; THOMSON, Kirsty; SAMUEL, Edward et al.Clinical infectious diseases. 2011, Vol 52, Num 1, pp 49-57, issn 1058-4838, 9 p.Article

Cytomegalovirus-Specific T Cell Immunotherapy Promotes Restoration of Durable Functional Antiviral Immunity following Allogeneic Stem Cell TransplantationPEGGS, Karl S; VERFUERTH, Stephanie; PIZZEY, Arnold et al.Clinical infectious diseases. 2009, Vol 49, Num 12, pp 1851-1860, issn 1058-4838, 10 p.Article

Development and clinical application of a fully controlled quantitative PCR assay for cell-free cytomegalovirus in human plasmaPREISER, Wolfgang; BRINK, Nicola S; AYLIFFE, Ursula et al.Journal of clinical virology. 2003, Vol 26, Num 1, pp 49-59, issn 1386-6532, 11 p.Article

Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complicationsMORRIS, Emma C; REBELLO, Peppy; THOMSON, Kirsty J et al.Blood. 2003, Vol 102, Num 1, pp 404-406, issn 0006-4971, 3 p.Article

Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioningTOWNSEND, William M; HOLROYD, Ailsa; HOWELL, David C. J et al.British journal of haematology. 2013, Vol 161, Num 4, pp 578-586, issn 0007-1048, 9 p.Article

Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemiaRICHARDSON, Simon E; KHAN, Iftekhar; BENJAMIN, Reuben et al.British journal of haematology. 2013, Vol 160, Num 5, pp 640-648, issn 0007-1048, 9 p.Article

  • Page / 2